ID   KGP1_HUMAN              Reviewed;         671 AA.
AC   Q13976; A5YM56; B3KSF3; E2PU10; P14619; Q5JP05; Q5JSJ6; Q6P5T7;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   12-OCT-2022, entry version 213.
DE   RecName: Full=cGMP-dependent protein kinase 1;
DE            Short=cGK 1;
DE            Short=cGK1;
DE            EC=2.7.11.12;
DE   AltName: Full=cGMP-dependent protein kinase I;
DE            Short=cGKI;
GN   Name=PRKG1; Synonyms=PRKG1B, PRKGR1A, PRKGR1B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM BETA).
RC   TISSUE=Placenta;
RX   PubMed=2792381; DOI=10.1016/0014-5793(89)81114-7;
RA   Sandberg M., Natarajan V., Ronander I., Kalderon D., Walter U.,
RA   Lohmann S.M., Jahnsen T.;
RT   "Molecular cloning and predicted full-length amino acid sequence of the
RT   type I beta isozyme of cGMP-dependent protein kinase from human placenta.
RT   Tissue distribution and developmental changes in rat.";
RL   FEBS Lett. 255:321-329(1989).
RN   [2]
RP   SEQUENCE REVISION.
RA   Sandberg M.;
RL   Submitted (OCT-1989) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA).
RC   TISSUE=Lung;
RX   PubMed=8613202; DOI=10.1161/01.hyp.27.3.552;
RA   Tamura N., Itoh H., Ogawa Y., Nakagawa O., Harada M., Chun T., Suga S.,
RA   Yoshimasa T., Nakao K.;
RT   "cDNA cloning and gene expression of human type Ialpha cGMP-dependent
RT   protein kinase.";
RL   Hypertension 27:552-557(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RX   PubMed=9192852; DOI=10.1006/geno.1997.4743;
RA   Orstavik S., Natarajan V., Tasken K., Jahnsen T., Sandberg M.;
RT   "Characterization of the human gene encoding the type I alpha and type I
RT   beta cGMP-dependent protein kinase (PRKG1).";
RL   Genomics 42:311-318(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM BETA).
RC   TISSUE=Cervix;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM BETA).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   FUNCTION IN PHOSPHORYLATION OF VASP.
RX   PubMed=8182057; DOI=10.1016/s0021-9258(17)36652-8;
RA   Butt E., Abel K., Krieger M., Palm D., Hoppe V., Hoppe J., Walter U.;
RT   "cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal
RT   adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in
RT   intact human platelets.";
RL   J. Biol. Chem. 269:14509-14517(1994).
RN   [11]
RP   INTERACTION WITH PPP1R12A, SUBUNIT, MUTAGENESIS OF LEU-12; ILE-19; LEU-26;
RP   ILE-33 AND LEU-40, AND FUNCTION.
RX   PubMed=10567269; DOI=10.1126/science.286.5444.1583;
RA   Surks H.K., Mochizuki N., Kasai Y., Georgescu S.P., Tang K.M., Ito M.,
RA   Lincoln T.M., Mendelsohn M.E.;
RT   "Regulation of myosin phosphatase by a specific interaction with cGMP-
RT   dependent protein kinase Ialpha.";
RL   Science 286:1583-1587(1999).
RN   [12]
RP   FUNCTION IN PHOSPHORYLATION OF RHOA.
RX   PubMed=11162591; DOI=10.1006/bbrc.2000.4194;
RA   Sawada N., Itoh H., Yamashita J., Doi K., Inoue M., Masatsugu K.,
RA   Fukunaga Y., Sakaguchi S., Sone M., Yamahara K., Yurugi T., Nakao K.;
RT   "cGMP-dependent protein kinase phosphorylates and inactivates RhoA.";
RL   Biochem. Biophys. Res. Commun. 280:798-805(2001).
RN   [13]
RP   FUNCTION IN PHOSPHORYLATION OF GTF2I, AND INTERACTION WITH GTF2I.
RX   PubMed=12082086; DOI=10.1074/jbc.m112332200;
RA   Casteel D.E., Zhuang S., Gudi T., Tang J., Vuica M., Desiderio S.,
RA   Pilz R.B.;
RT   "cGMP-dependent protein kinase I beta physically and functionally interacts
RT   with the transcriptional regulator TFII-I.";
RL   J. Biol. Chem. 277:32003-32014(2002).
RN   [14]
RP   FUNCTION IN PHOSPHORYLATION OF PDE5.
RX   PubMed=11723116; DOI=10.1074/jbc.m106562200;
RA   Rybalkin S.D., Rybalkina I.G., Feil R., Hofmann F., Beavo J.A.;
RT   "Regulation of cGMP-specific phosphodiesterase (PDE5) phosphorylation in
RT   smooth muscle cells.";
RL   J. Biol. Chem. 277:3310-3317(2002).
RN   [15]
RP   FUNCTION IN PHOSPHORYLATION OF RGS2, AND INTERACTION WITH RGS2.
RX   PubMed=14608379; DOI=10.1038/nm958;
RA   Tang K.M., Wang G.R., Lu P., Karas R.H., Aronovitz M., Heximer S.P.,
RA   Kaltenbronn K.M., Blumer K.J., Siderovski D.P., Zhu Y., Mendelsohn M.E.;
RT   "Regulator of G-protein signaling-2 mediates vascular smooth muscle
RT   relaxation and blood pressure.";
RL   Nat. Med. 9:1506-1512(2003).
RN   [16]
RP   FUNCTION.
RX   PubMed=15194681; DOI=10.1074/jbc.m405957200;
RA   Wooldridge A.A., MacDonald J.A., Erdodi F., Ma C., Borman M.A.,
RA   Hartshorne D.J., Haystead T.A.J.;
RT   "Smooth muscle phosphatase is regulated in vivo by exclusion of
RT   phosphorylation of threonine 696 of MYPT1 by phosphorylation of Serine 695
RT   in response to cyclic nucleotides.";
RL   J. Biol. Chem. 279:34496-34504(2004).
RN   [17]
RP   FUNCTION IN THE INHIBITION OF PLATELET AGGREGATION, FUNCTION IN
RP   PHOSPHORYLATION OF IRAG1, SUBCELLULAR LOCATION, AND INTERACTION WITH IRAG1
RP   AND ITPR1.
RX   PubMed=16990611; DOI=10.1182/blood-2005-10-026294;
RA   Antl M., von Bruehl M.-L., Eiglsperger C., Werner M., Konrad I., Kocher T.,
RA   Wilm M., Hofmann F., Massberg S., Schlossmann J.;
RT   "IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and
RT   thrombus formation.";
RL   Blood 109:552-559(2007).
RN   [18]
RP   INTERACTION WITH PPP1R12A.
RX   PubMed=17904578; DOI=10.1016/j.jmb.2007.08.049;
RA   Lee E., Hayes D.B., Langsetmo K., Sundberg E.J., Tao T.C.;
RT   "Interactions between the leucine-zipper motif of cGMP-dependent protein
RT   kinase and the C-terminal region of the targeting subunit of myosin light
RT   chain phosphatase.";
RL   J. Mol. Biol. 373:1198-1212(2007).
RN   [19]
RP   INTERACTION WITH PPP1R12A, AND SUBUNIT.
RX   PubMed=18782776; DOI=10.1074/jbc.m804916200;
RA   Sharma A.K., Zhou G.-P., Kupferman J., Surks H.K., Christensen E.N.,
RA   Chou J.J., Mendelsohn M.E., Rigby A.C.;
RT   "Probing the interaction between the coiled coil leucine zipper of cGMP-
RT   dependent protein kinase Ialpha and the C terminus of the myosin binding
RT   subunit of the myosin light chain phosphatase.";
RL   J. Biol. Chem. 283:32860-32869(2008).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [21]
RP   REVIEW.
RX   PubMed=20716671; DOI=10.1124/pr.110.002907;
RA   Francis S.H., Busch J.L., Corbin J.D., Sibley D.;
RT   "cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide
RT   and cGMP action.";
RL   Pharmacol. Rev. 62:525-563(2010).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [23]
RP   FUNCTION (ISOFORM ALPHA) IN PHOSPHORYLATION OF TRPC7, INTERACTION WITH
RP   TRPC7, AND SUBCELLULAR LOCATION.
RX   PubMed=21402151; DOI=10.1016/j.cellsig.2011.03.005;
RA   Yuasa K., Matsuda T., Tsuji A.;
RT   "Functional regulation of transient receptor potential canonical 7 by cGMP-
RT   dependent protein kinase Ialpha.";
RL   Cell. Signal. 23:1179-1187(2011).
RN   [24]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [25]
RP   STRUCTURE BY NMR OF 2-58, INTERACTION WITH PPP1R12A, SUBUNIT, AND
RP   COILED-COIL.
RX   PubMed=16131665; DOI=10.1110/ps.051528905;
RA   Schnell J.R., Zhou G.-P., Zweckstetter M., Rigby A.C., Chou J.J.;
RT   "Rapid and accurate structure determination of coiled-coil domains using
RT   NMR dipolar couplings: application to cGMP-dependent protein kinase
RT   Ialpha.";
RL   Protein Sci. 14:2421-2428(2005).
RN   [26] {ECO:0007744|PDB:3NMD}
RP   X-RAY CRYSTALLOGRAPHY (2.27 ANGSTROMS) OF 4-55 (ISOFORM BETA), AND SUBUNIT.
RX   PubMed=20826808; DOI=10.1074/jbc.c110.161430;
RA   Casteel D.E., Smith-Nguyen E.V., Sankaran B., Roh S.H., Pilz R.B., Kim C.;
RT   "A crystal structure of the cyclic GMP-dependent protein kinase I{beta}
RT   dimerization/docking domain reveals molecular details of isoform-specific
RT   anchoring.";
RL   J. Biol. Chem. 285:32684-32688(2010).
RN   [27] {ECO:0007744|PDB:3OCP, ECO:0007744|PDB:3OD0, ECO:0007744|PDB:3OGJ}
RP   X-RAY CRYSTALLOGRAPHY (2.49 ANGSTROMS) OF 92-227 (ISOFORM BETA) IN COMPLEX
RP   WITH CGMP AND CAMP.
RX   PubMed=21526164; DOI=10.1371/journal.pone.0018413;
RA   Kim J.J., Casteel D.E., Huang G., Kwon T.H., Ren R.K., Zwart P.,
RA   Headd J.J., Brown N.G., Chow D.C., Palzkill T., Kim C.;
RT   "Co-crystal structures of PKG Ibeta (92-227) with cGMP and cAMP reveal the
RT   molecular details of cyclic-nucleotide binding.";
RL   PLoS ONE 6:E18413-E18413(2011).
RN   [28] {ECO:0007744|PDB:4QX5, ECO:0007744|PDB:4QXK}
RP   X-RAY CRYSTALLOGRAPHY (1.32 ANGSTROMS) OF 204-354 (ISOFORM BETA) IN COMPLEX
RP   WITH CAMP AND CGMP.
RX   PubMed=25271401; DOI=10.1021/bi501012v;
RA   Huang G.Y., Gerlits O.O., Blakeley M.P., Sankaran B., Kovalevsky A.Y.,
RA   Kim C.;
RT   "Neutron diffraction reveals hydrogen bonds critical for cGMP-selective
RT   activation: insights for cGMP-dependent protein kinase agonist design.";
RL   Biochemistry 53:6725-6727(2014).
RN   [29] {ECO:0007744|PDB:4KU7, ECO:0007744|PDB:4KU8}
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 204-354 (ISOFORM BETA) IN COMPLEX
RP   WITH CGMP, AND MUTAGENESIS OF LEU-281; ARG-282; THR-302 AND TYR-336.
RX   PubMed=24239458; DOI=10.1016/j.str.2013.09.021;
RA   Huang G.Y., Kim J.J., Reger A.S., Lorenz R., Moon E.W., Zhao C.,
RA   Casteel D.E., Bertinetti D., Vanschouwen B., Selvaratnam R.,
RA   Pflugrath J.W., Sankaran B., Melacini G., Herberg F.W., Kim C.;
RT   "Structural basis for cyclic-nucleotide selectivity and cGMP-selective
RT   activation of PKG I.";
RL   Structure 22:116-124(2014).
RN   [30]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-249 AND SER-267.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [31]
RP   VARIANT AAT8 GLN-177, VARIANTS PHE-474 AND ALA-666, AND CHARACTERIZATION OF
RP   VARIANT AAT8 GLN-177.
RX   PubMed=23910461; DOI=10.1016/j.ajhg.2013.06.019;
RG   GenTAC Registry Consortium;
RG   National Heart, Lung, and Blood Institute Grand Opportunity Exome Sequencing Project;
RA   Guo D.C., Regalado E., Casteel D.E., Santos-Cortez R.L., Gong L., Kim J.J.,
RA   Dyack S., Horne S.G., Chang G., Jondeau G., Boileau C., Coselli J.S.,
RA   Li Z., Leal S.M., Shendure J., Rieder M.J., Bamshad M.J., Nickerson D.A.,
RA   Kim C., Milewicz D.M.;
RT   "Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic
RT   aneurysms and acute aortic dissections.";
RL   Am. J. Hum. Genet. 93:398-404(2013).
CC   -!- FUNCTION: Serine/threonine protein kinase that acts as key mediator of
CC       the nitric oxide (NO)/cGMP signaling pathway. GMP binding activates
CC       PRKG1, which phosphorylates serines and threonines on many cellular
CC       proteins. Numerous protein targets for PRKG1 phosphorylation are
CC       implicated in modulating cellular calcium, but the contribution of each
CC       of these targets may vary substantially among cell types. Proteins that
CC       are phosphorylated by PRKG1 regulate platelet activation and adhesion,
CC       smooth muscle contraction, cardiac function, gene expression, feedback
CC       of the NO-signaling pathway, and other processes involved in several
CC       aspects of the CNS like axon guidance, hippocampal and cerebellar
CC       learning, circadian rhythm and nociception. Smooth muscle relaxation is
CC       mediated through lowering of intracellular free calcium, by
CC       desensitization of contractile proteins to calcium, and by decrease in
CC       the contractile state of smooth muscle or in platelet activation.
CC       Regulates intracellular calcium levels via several pathways:
CC       phosphorylates IRAG1 and inhibits IP3-induced Ca(2+) release from
CC       intracellular stores, phosphorylation of KCNMA1 (BKCa) channels
CC       decreases intracellular Ca(2+) levels, which leads to increased opening
CC       of this channel. PRKG1 phosphorylates the canonical transient receptor
CC       potential channel (TRPC) family which inactivates the associated inward
CC       calcium current. Another mode of action of NO/cGMP/PKGI signaling
CC       involves PKGI-mediated inactivation of the Ras homolog gene family
CC       member A (RhoA). Phosphorylation of RHOA by PRKG1 blocks the action of
CC       this protein in myriad processes: regulation of RHOA translocation;
CC       decreasing contraction; controlling vesicle trafficking, reduction of
CC       myosin light chain phosphorylation resulting in vasorelaxation.
CC       Activation of PRKG1 by NO signaling alters also gene expression in a
CC       number of tissues. In smooth muscle cells, increased cGMP and PRKG1
CC       activity influence expression of smooth muscle-specific contractile
CC       proteins, levels of proteins in the NO/cGMP signaling pathway, down-
CC       regulation of the matrix proteins osteopontin and thrombospondin-1 to
CC       limit smooth muscle cell migration and phenotype. Regulates
CC       vasodilator-stimulated phosphoprotein (VASP) functions in platelets and
CC       smooth muscle. {ECO:0000269|PubMed:10567269,
CC       ECO:0000269|PubMed:11162591, ECO:0000269|PubMed:11723116,
CC       ECO:0000269|PubMed:12082086, ECO:0000269|PubMed:14608379,
CC       ECO:0000269|PubMed:15194681, ECO:0000269|PubMed:16990611,
CC       ECO:0000269|PubMed:8182057}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.12;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.12;
CC   -!- ACTIVITY REGULATION: In the absence of cGMP, PRKG1 activity is
CC       suppressed by autoinhibitory contacts.
CC   -!- SUBUNIT: Isoform alpha: parallel homodimer or heterodimer and also
CC       heterotetramer. Interacts directly with PPP1R12A. Non-covalent dimer of
CC       dimer of PRKG1-PRKG1 and PPP1R12A-PPP1R12A. This interaction targets
CC       PRKG1 to stress fibers to mediate smooth muscle cell relaxation and
CC       vasodilation in responses to rises in cGMP. Isoform beta: antiparallel
CC       homodimer. Part of cGMP kinase signaling complex at least composed of
CC       ACTA2/alpha-actin, CNN1/calponin H1, PLN/phospholamban, PRKG1 and ITPR1
CC       (By similarity). Interacts with IRAG1. Forms a stable complex with
CC       ITPR1, IRAG1, and isoform beta of PRKG1. Interacts with TRPC7 (via
CC       ankyrin repeat domain). Isoform alpha interacts with RGS2. Interacts
CC       with GTF2I. {ECO:0000250, ECO:0000269|PubMed:10567269,
CC       ECO:0000269|PubMed:12082086, ECO:0000269|PubMed:14608379,
CC       ECO:0000269|PubMed:16131665, ECO:0000269|PubMed:16990611,
CC       ECO:0000269|PubMed:17904578, ECO:0000269|PubMed:18782776,
CC       ECO:0000269|PubMed:20826808, ECO:0000269|PubMed:21402151}.
CC   -!- INTERACTION:
CC       Q13976; Q13873: BMPR2; NbExp=2; IntAct=EBI-3952014, EBI-527196;
CC       Q13976; Q86V42: FAM124A; NbExp=4; IntAct=EBI-3952014, EBI-744506;
CC       Q13976; P25791: LMO2; NbExp=4; IntAct=EBI-3952014, EBI-739696;
CC       Q13976; O76074: PDE5A; NbExp=4; IntAct=EBI-3952014, EBI-9023531;
CC       Q13976; O15015: ZNF646; NbExp=4; IntAct=EBI-3952014, EBI-745608;
CC       Q13976-2; O94989: ARHGEF15; NbExp=3; IntAct=EBI-4280187, EBI-740691;
CC       Q13976-2; P25791-3: LMO2; NbExp=3; IntAct=EBI-4280187, EBI-11959475;
CC       Q13976-2; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-4280187, EBI-16439278;
CC       Q13976-2; Q13976-2: PRKG1; NbExp=3; IntAct=EBI-4280187, EBI-4280187;
CC       Q13976-2; Q9NYW8: RBAK; NbExp=3; IntAct=EBI-4280187, EBI-1210429;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Note=Colocalized with
CC       TRPC7 in the plasma membrane. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=Alpha; Synonyms=CGK1-alpha;
CC         IsoId=Q13976-1; Sequence=Displayed;
CC       Name=Beta; Synonyms=CGK1-beta;
CC         IsoId=Q13976-2, P14619-1; Sequence=VSP_038714;
CC       Name=3;
CC         IsoId=Q13976-3; Sequence=VSP_055541, VSP_055542;
CC   -!- TISSUE SPECIFICITY: Primarily expressed in lung and placenta.
CC       {ECO:0000269|PubMed:9192852}.
CC   -!- DOMAIN: Composed of an N-terminal leucine-zipper domain followed by an
CC       autoinhibitory domain, which mediate homodimer formation and inhibit
CC       kinase activity, respectively. Next, two cGMP-binding domains are
CC       followed by the catalytic domain at the C-terminus. Binding of cGMP to
CC       cGMP-binding domains results in a conformational change that activates
CC       kinase activity by removing the autoinhibitory domain from the
CC       catalytic cleft leaving the catalytic domain free to phosphorylate
CC       downstream substrates. Isoforms alpha and beta have identical cGMP-
CC       binding and catalytic domains but differ in their leucine zipper and
CC       autoinhibitory sequences and therefore differ in their dimerization
CC       substrates and kinase enzyme activity.
CC   -!- DOMAIN: Heterotetramerization is mediated by the interaction between a
CC       coiled-coil of PRKG1 and the leucine/isoleucine zipper of PPP1R12A/MBS,
CC       the myosin-binding subunit of the myosin phosphatase.
CC   -!- PTM: Autophosphorylation increases kinase activity.
CC   -!- PTM: 65 kDa monomer is produced by proteolytic cleavage. {ECO:0000250}.
CC   -!- DISEASE: Aortic aneurysm, familial thoracic 8 (AAT8) [MIM:615436]: A
CC       disease characterized by permanent dilation of the thoracic aorta
CC       usually due to degenerative changes in the aortic wall. It is primarily
CC       associated with a characteristic histologic appearance known as 'medial
CC       necrosis' or 'Erdheim cystic medial necrosis' in which there is
CC       degeneration and fragmentation of elastic fibers, loss of smooth muscle
CC       cells, and an accumulation of basophilic ground substance.
CC       {ECO:0000269|PubMed:23910461}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: The 3D structures in complex with cGMP and cAMP describe
CC       the hydrogen bonding interactions that modulate high selectivity for
CC       cGMP in the CNB-B domain, and reveal that all these contacts are
CC       disrupted in the structure with cAMP, explaining the low affinity of
CC       the enzyme for cAMP and the fact that cAMP can only weakly activate
CC       PKG. {ECO:0000269|PubMed:25271401}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. cGMP subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y07512; CAA68810.1; -; mRNA.
DR   EMBL; D45864; BAA08297.1; -; mRNA.
DR   EMBL; AK093436; BAG52715.1; -; mRNA.
DR   EMBL; EF560730; ABQ59040.1; -; mRNA.
DR   EMBL; Z92867; CAB07436.1; -; Genomic_DNA.
DR   EMBL; Z92869; CAB07436.1; JOINED; Genomic_DNA.
DR   EMBL; Z92870; CAB07436.1; JOINED; Genomic_DNA.
DR   EMBL; Z92871; CAB07436.1; JOINED; Genomic_DNA.
DR   EMBL; Z92872; CAB07436.1; JOINED; Genomic_DNA.
DR   EMBL; Z92873; CAB07436.1; JOINED; Genomic_DNA.
DR   EMBL; Z92874; CAB07436.1; JOINED; Genomic_DNA.
DR   EMBL; Z92875; CAB07436.1; JOINED; Genomic_DNA.
DR   EMBL; Z92876; CAB07436.1; JOINED; Genomic_DNA.
DR   EMBL; Z92877; CAB07436.1; JOINED; Genomic_DNA.
DR   EMBL; Z92878; CAB07436.1; JOINED; Genomic_DNA.
DR   EMBL; Z92879; CAB07436.1; JOINED; Genomic_DNA.
DR   EMBL; Z92880; CAB07436.1; JOINED; Genomic_DNA.
DR   EMBL; Z92881; CAB07436.1; JOINED; Genomic_DNA.
DR   EMBL; Z92882; CAB07436.1; JOINED; Genomic_DNA.
DR   EMBL; Z92883; CAB07436.1; JOINED; Genomic_DNA.
DR   EMBL; Z92884; CAB07436.1; JOINED; Genomic_DNA.
DR   EMBL; Z92885; CAB07436.1; JOINED; Genomic_DNA.
DR   EMBL; Z92868; CAB07437.1; -; Genomic_DNA.
DR   EMBL; Z92869; CAB07437.1; JOINED; Genomic_DNA.
DR   EMBL; Z92870; CAB07437.1; JOINED; Genomic_DNA.
DR   EMBL; Z92871; CAB07437.1; JOINED; Genomic_DNA.
DR   EMBL; Z92872; CAB07437.1; JOINED; Genomic_DNA.
DR   EMBL; Z92873; CAB07437.1; JOINED; Genomic_DNA.
DR   EMBL; Z92874; CAB07437.1; JOINED; Genomic_DNA.
DR   EMBL; Z92875; CAB07437.1; JOINED; Genomic_DNA.
DR   EMBL; Z92876; CAB07437.1; JOINED; Genomic_DNA.
DR   EMBL; Z92877; CAB07437.1; JOINED; Genomic_DNA.
DR   EMBL; Z92878; CAB07437.1; JOINED; Genomic_DNA.
DR   EMBL; Z92879; CAB07437.1; JOINED; Genomic_DNA.
DR   EMBL; Z92880; CAB07437.1; JOINED; Genomic_DNA.
DR   EMBL; Z92881; CAB07437.1; JOINED; Genomic_DNA.
DR   EMBL; Z92882; CAB07437.1; JOINED; Genomic_DNA.
DR   EMBL; Z92883; CAB07437.1; JOINED; Genomic_DNA.
DR   EMBL; Z92884; CAB07437.1; JOINED; Genomic_DNA.
DR   EMBL; Z92885; CAB07437.1; JOINED; Genomic_DNA.
DR   EMBL; AL391378; CAI39626.1; -; Genomic_DNA.
DR   EMBL; AC009986; CAI39626.1; JOINED; Genomic_DNA.
DR   EMBL; AC022537; CAI39626.1; JOINED; Genomic_DNA.
DR   EMBL; AC022025; CAI39626.1; JOINED; Genomic_DNA.
DR   EMBL; AC027118; CAI39626.1; JOINED; Genomic_DNA.
DR   EMBL; AL731537; CAI39626.1; JOINED; Genomic_DNA.
DR   EMBL; AL928686; CAI39626.1; JOINED; Genomic_DNA.
DR   EMBL; AL157399; CAI39626.1; JOINED; Genomic_DNA.
DR   EMBL; AC026228; CAI39626.1; JOINED; Genomic_DNA.
DR   EMBL; AL928686; CAI40743.1; -; Genomic_DNA.
DR   EMBL; AC009986; CAI40743.1; JOINED; Genomic_DNA.
DR   EMBL; AC022537; CAI40743.1; JOINED; Genomic_DNA.
DR   EMBL; AL731537; CAI40743.1; JOINED; Genomic_DNA.
DR   EMBL; AL391378; CAI40743.1; JOINED; Genomic_DNA.
DR   EMBL; AL157399; CAI40743.1; JOINED; Genomic_DNA.
DR   EMBL; AC027118; CAI40743.1; JOINED; Genomic_DNA.
DR   EMBL; AC026228; CAI40743.1; JOINED; Genomic_DNA.
DR   EMBL; AC022025; CAI40743.1; JOINED; Genomic_DNA.
DR   EMBL; AL157399; CAI41305.1; -; Genomic_DNA.
DR   EMBL; AC022025; CAI41305.1; JOINED; Genomic_DNA.
DR   EMBL; AC009986; CAI41305.1; JOINED; Genomic_DNA.
DR   EMBL; AL928686; CAI41305.1; JOINED; Genomic_DNA.
DR   EMBL; AL731537; CAI41305.1; JOINED; Genomic_DNA.
DR   EMBL; AL391378; CAI41305.1; JOINED; Genomic_DNA.
DR   EMBL; AC027118; CAI41305.1; JOINED; Genomic_DNA.
DR   EMBL; AC026228; CAI41305.1; JOINED; Genomic_DNA.
DR   EMBL; AC022537; CAI41305.1; JOINED; Genomic_DNA.
DR   EMBL; AL731537; CAI17115.1; -; Genomic_DNA.
DR   EMBL; AL928686; CAI17115.1; JOINED; Genomic_DNA.
DR   EMBL; AL391378; CAI17115.1; JOINED; Genomic_DNA.
DR   EMBL; AL157399; CAI17115.1; JOINED; Genomic_DNA.
DR   EMBL; AC027118; CAI17115.1; JOINED; Genomic_DNA.
DR   EMBL; AC026228; CAI17115.1; JOINED; Genomic_DNA.
DR   EMBL; AC022537; CAI17115.1; JOINED; Genomic_DNA.
DR   EMBL; AC022025; CAI17115.1; JOINED; Genomic_DNA.
DR   EMBL; AC009986; CAI17115.1; JOINED; Genomic_DNA.
DR   EMBL; AC068062; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC069079; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC073584; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL596105; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL607031; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471083; EAW54140.1; -; Genomic_DNA.
DR   EMBL; BC062688; AAH62688.1; -; mRNA.
DR   EMBL; BC127090; AAI27091.1; -; mRNA.
DR   CCDS; CCDS44399.1; -. [Q13976-1]
DR   CCDS; CCDS7244.1; -. [Q13976-2]
DR   PIR; S05702; S05702.
DR   RefSeq; NP_001091982.1; NM_001098512.2. [Q13976-1]
DR   RefSeq; NP_006249.1; NM_006258.3. [Q13976-2]
DR   PDB; 1ZXA; NMR; -; A/B=2-59.
DR   PDB; 3NMD; X-ray; 2.27 A; A/B/C/D/E=4-47.
DR   PDB; 3OCP; X-ray; 2.49 A; A/B=84-212.
DR   PDB; 3OD0; X-ray; 2.90 A; A/B=84-212.
DR   PDB; 3OGJ; X-ray; 2.75 A; A/B/C/D=84-212.
DR   PDB; 4KU7; X-ray; 1.65 A; A=204-354.
DR   PDB; 4KU8; X-ray; 1.99 A; A/B/C=204-354.
DR   PDB; 4QX5; X-ray; 1.32 A; A=204-354.
DR   PDB; 4QXK; Other; 2.20 A; A=204-354.
DR   PDB; 4R4L; X-ray; 2.25 A; A/B/C=2-48.
DR   PDB; 4R4M; X-ray; 1.92 A; A/B/C=2-48.
DR   PDB; 4Z07; X-ray; 2.50 A; A/C/E=84-336.
DR   PDB; 5J48; X-ray; 1.49 A; A/B=204-336.
DR   PDB; 5JAX; X-ray; 1.49 A; A=204-336.
DR   PDB; 5JD7; X-ray; 1.75 A; A=204-336.
DR   PDB; 5L0N; X-ray; 1.28 A; A=204-336.
DR   PDB; 6BDL; X-ray; 1.96 A; A/B=327-671.
DR   PDB; 6BG2; X-ray; 1.83 A; A/B/C/D=327-671.
DR   PDB; 6C0T; X-ray; 1.98 A; A=327-671.
DR   PDBsum; 1ZXA; -.
DR   PDBsum; 3NMD; -.
DR   PDBsum; 3OCP; -.
DR   PDBsum; 3OD0; -.
DR   PDBsum; 3OGJ; -.
DR   PDBsum; 4KU7; -.
DR   PDBsum; 4KU8; -.
DR   PDBsum; 4QX5; -.
DR   PDBsum; 4QXK; -.
DR   PDBsum; 4R4L; -.
DR   PDBsum; 4R4M; -.
DR   PDBsum; 4Z07; -.
DR   PDBsum; 5J48; -.
DR   PDBsum; 5JAX; -.
DR   PDBsum; 5JD7; -.
DR   PDBsum; 5L0N; -.
DR   PDBsum; 6BDL; -.
DR   PDBsum; 6BG2; -.
DR   PDBsum; 6C0T; -.
DR   AlphaFoldDB; Q13976; -.
DR   BMRB; Q13976; -.
DR   SMR; Q13976; -.
DR   BioGRID; 111578; 35.
DR   DIP; DIP-41118N; -.
DR   DIP; DIP-46288N; -.
DR   IntAct; Q13976; 26.
DR   MINT; Q13976; -.
DR   STRING; 9606.ENSP00000363092; -.
DR   BindingDB; Q13976; -.
DR   ChEMBL; CHEMBL4273; -.
DR   DrugCentral; Q13976; -.
DR   GuidetoPHARMACOLOGY; 1492; -.
DR   GlyGen; Q13976; 1 site, 2 O-linked glycans (1 site).
DR   iPTMnet; Q13976; -.
DR   MetOSite; Q13976; -.
DR   PhosphoSitePlus; Q13976; -.
DR   BioMuta; PRKG1; -.
DR   DMDM; 6225588; -.
DR   EPD; Q13976; -.
DR   jPOST; Q13976; -.
DR   MassIVE; Q13976; -.
DR   MaxQB; Q13976; -.
DR   PeptideAtlas; Q13976; -.
DR   PRIDE; Q13976; -.
DR   ProteomicsDB; 59781; -. [Q13976-1]
DR   ProteomicsDB; 59782; -. [Q13976-2]
DR   Antibodypedia; 2108; 343 antibodies from 37 providers.
DR   DNASU; 5592; -.
DR   Ensembl; ENST00000373980.11; ENSP00000363092.5; ENSG00000185532.20. [Q13976-2]
DR   Ensembl; ENST00000401604.8; ENSP00000384200.4; ENSG00000185532.20. [Q13976-1]
DR   GeneID; 5592; -.
DR   KEGG; hsa:5592; -.
DR   MANE-Select; ENST00000373980.11; ENSP00000363092.5; NM_006258.4; NP_006249.1. [Q13976-2]
DR   UCSC; uc001jjo.4; human. [Q13976-1]
DR   CTD; 5592; -.
DR   DisGeNET; 5592; -.
DR   GeneCards; PRKG1; -.
DR   HGNC; HGNC:9414; PRKG1.
DR   HPA; ENSG00000185532; Tissue enhanced (tongue).
DR   MalaCards; PRKG1; -.
DR   MIM; 176894; gene.
DR   MIM; 615436; phenotype.
DR   neXtProt; NX_Q13976; -.
DR   OpenTargets; ENSG00000185532; -.
DR   Orphanet; 91387; Familial thoracic aortic aneurysm and aortic dissection.
DR   PharmGKB; PA33777; -.
DR   VEuPathDB; HostDB:ENSG00000185532; -.
DR   eggNOG; KOG0614; Eukaryota.
DR   GeneTree; ENSGT00940000154704; -.
DR   HOGENOM; CLU_000288_73_2_1; -.
DR   InParanoid; Q13976; -.
DR   OMA; XTHYENG; -.
DR   OrthoDB; 401933at2759; -.
DR   PhylomeDB; Q13976; -.
DR   TreeFam; TF313261; -.
DR   BRENDA; 2.7.11.12; 2681.
DR   PathwayCommons; Q13976; -.
DR   Reactome; R-HSA-392517; Rap1 signalling. [Q13976-1]
DR   Reactome; R-HSA-4086398; Ca2+ pathway.
DR   Reactome; R-HSA-418457; cGMP effects. [Q13976-1]
DR   SABIO-RK; Q13976; -.
DR   SignaLink; Q13976; -.
DR   SIGNOR; Q13976; -.
DR   BioGRID-ORCS; 5592; 19 hits in 1110 CRISPR screens.
DR   ChiTaRS; PRKG1; human.
DR   EvolutionaryTrace; Q13976; -.
DR   GeneWiki; PRKG1; -.
DR   GenomeRNAi; 5592; -.
DR   Pharos; Q13976; Tchem.
DR   PRO; PR:Q13976; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q13976; protein.
DR   Bgee; ENSG00000185532; Expressed in saphenous vein and 170 other tissues.
DR   ExpressionAtlas; Q13976; baseline and differential.
DR   Genevisible; Q13976; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005246; F:calcium channel regulator activity; IDA:UniProtKB.
DR   GO; GO:0030553; F:cGMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004692; F:cGMP-dependent protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0004672; F:protein kinase activity; IMP:BHF-UCL.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0030036; P:actin cytoskeleton organization; TAS:ProtInc.
DR   GO; GO:0019934; P:cGMP-mediated signaling; IEA:Ensembl.
DR   GO; GO:0016358; P:dendrite development; IEA:Ensembl.
DR   GO; GO:0030900; P:forebrain development; IEA:Ensembl.
DR   GO; GO:0090331; P:negative regulation of platelet aggregation; IMP:UniProtKB.
DR   GO; GO:1904753; P:negative regulation of vascular associated smooth muscle cell migration; IDA:BHF-UCL.
DR   GO; GO:1904706; P:negative regulation of vascular associated smooth muscle cell proliferation; IDA:BHF-UCL.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0043087; P:regulation of GTPase activity; IMP:UniProtKB.
DR   GO; GO:0060087; P:relaxation of vascular associated smooth muscle; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   CDD; cd00038; CAP_ED; 2.
DR   CDD; cd05572; STKc_cGK; 1.
DR   Gene3D; 2.60.120.10; -; 2.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR002374; cGMP_dep_kinase.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR018490; cNMP-bd_dom_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR031831; PKcGMP_CC.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR035014; STKc_cGK.
DR   Pfam; PF00027; cNMP_binding; 2.
DR   Pfam; PF16808; PKcGMP_CC; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF000559; cGMP-dep_kinase; 1.
DR   PRINTS; PR00104; CGMPKINASE.
DR   SMART; SM00100; cNMP; 2.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF51206; SSF51206; 2.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 2.
DR   PROSITE; PS00889; CNMP_BINDING_2; 2.
DR   PROSITE; PS50042; CNMP_BINDING_3; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Allosteric enzyme; Alternative splicing;
KW   Aortic aneurysm; ATP-binding; cGMP; cGMP-binding; Coiled coil; Cytoplasm;
KW   Disease variant; Disulfide bond; Kinase; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:22223895"
FT   CHAIN           2..671
FT                   /note="cGMP-dependent protein kinase 1"
FT                   /id="PRO_0000086115"
FT   DOMAIN          360..619
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          620..671
FT                   /note="AGC-kinase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00618"
FT   REGION          2..102
FT                   /note="Required for dimerization"
FT   REGION          9..44
FT                   /note="Leucine-zipper"
FT   REGION          50..75
FT                   /note="Autoinhibitory domain"
FT                   /evidence="ECO:0000250"
FT   REGION          103..220
FT                   /note="cGMP-binding, high affinity"
FT   REGION          221..341
FT                   /note="cGMP-binding, low affinity"
FT   REGION          635..671
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          2..59
FT                   /evidence="ECO:0000269|PubMed:16131665"
FT   COMPBIAS        651..671
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        484
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         167..170
FT                   /ligand="3',5'-cyclic AMP"
FT                   /ligand_id="ChEBI:CHEBI:58165"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:21526164,
FT                   ECO:0007744|PDB:3OCP, ECO:0007744|PDB:3OGJ"
FT   BINDING         167..170
FT                   /ligand="3',5'-cyclic GMP"
FT                   /ligand_id="ChEBI:CHEBI:57746"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:21526164,
FT                   ECO:0007744|PDB:3OD0"
FT   BINDING         177..178
FT                   /ligand="3',5'-cyclic AMP"
FT                   /ligand_id="ChEBI:CHEBI:58165"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:21526164,
FT                   ECO:0007744|PDB:3OCP, ECO:0007744|PDB:3OGJ"
FT   BINDING         177..178
FT                   /ligand="3',5'-cyclic GMP"
FT                   /ligand_id="ChEBI:CHEBI:57746"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:21526164,
FT                   ECO:0007744|PDB:3OD0"
FT   BINDING         282
FT                   /ligand="3',5'-cyclic GMP"
FT                   /ligand_id="ChEBI:CHEBI:57746"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:24239458,
FT                   ECO:0000269|PubMed:25271401, ECO:0007744|PDB:4KU7,
FT                   ECO:0007744|PDB:4QXK"
FT   BINDING         291..294
FT                   /ligand="3',5'-cyclic AMP"
FT                   /ligand_id="ChEBI:CHEBI:58165"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:25271401,
FT                   ECO:0007744|PDB:4QX5"
FT   BINDING         291..294
FT                   /ligand="3',5'-cyclic GMP"
FT                   /ligand_id="ChEBI:CHEBI:57746"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:24239458,
FT                   ECO:0000269|PubMed:25271401, ECO:0007744|PDB:4KU7,
FT                   ECO:0007744|PDB:4QXK"
FT   BINDING         301..302
FT                   /ligand="3',5'-cyclic AMP"
FT                   /ligand_id="ChEBI:CHEBI:58165"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:25271401,
FT                   ECO:0007744|PDB:4QX5"
FT   BINDING         301..302
FT                   /ligand="3',5'-cyclic GMP"
FT                   /ligand_id="ChEBI:CHEBI:57746"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:24239458,
FT                   ECO:0000269|PubMed:25271401, ECO:0007744|PDB:4KU7,
FT                   ECO:0007744|PDB:4QXK"
FT   BINDING         336
FT                   /ligand="3',5'-cyclic AMP"
FT                   /ligand_id="ChEBI:CHEBI:58165"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:25271401,
FT                   ECO:0007744|PDB:4QX5"
FT   BINDING         336
FT                   /ligand="3',5'-cyclic GMP"
FT                   /ligand_id="ChEBI:CHEBI:57746"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:24239458,
FT                   ECO:0000269|PubMed:25271401, ECO:0007744|PDB:4KU7,
FT                   ECO:0007744|PDB:4QXK"
FT   BINDING         366..374
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         390
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0007744|PubMed:22223895"
FT   MOD_RES         59
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P00516"
FT   MOD_RES         515
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P0C605"
FT   DISULFID        43
FT                   /note="Interchain"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1..89
FT                   /note="MSELEEDFAKILMLKEERIKELEKRLSEKEEEIQELKRKLHKCQSVLPVPST
FT                   HIGPRTTRAQGISAEPQTYRSFHDLRQAFRKFTKSER -> MGTLRDLQYALQEKIEEL
FT                   RQRDALIDELELELDQKDELIQKLQNELDKYRSVIRPATQQAQKQSASTLQGEPRTKRQ
FT                   AISAEPTAFDIQDLSHVTLPFYPKSPQ (in isoform Beta)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:17974005, ECO:0000303|PubMed:2792381"
FT                   /id="VSP_038714"
FT   VAR_SEQ         1..15
FT                   /note="MSELEEDFAKILMLK -> MEKQNMFLHGSYILR (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055541"
FT   VAR_SEQ         16..297
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055542"
FT   VARIANT         177
FT                   /note="R -> Q (in AAT8; impairs cGMP binding; the mutant
FT                   protein is constitutively active; dbSNP:rs397515330)"
FT                   /evidence="ECO:0000269|PubMed:23910461"
FT                   /id="VAR_070434"
FT   VARIANT         249
FT                   /note="I -> V (in dbSNP:rs56082459)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_046773"
FT   VARIANT         267
FT                   /note="N -> S (in dbSNP:rs34997494)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_051632"
FT   VARIANT         474
FT                   /note="Y -> F (in dbSNP:rs149710600)"
FT                   /evidence="ECO:0000269|PubMed:23910461"
FT                   /id="VAR_070435"
FT   VARIANT         666
FT                   /note="G -> A (in dbSNP:rs750949508)"
FT                   /evidence="ECO:0000269|PubMed:23910461"
FT                   /id="VAR_070436"
FT   MUTAGEN         12
FT                   /note="L->A: Loss of binding to PPP1R12A."
FT                   /evidence="ECO:0000269|PubMed:10567269"
FT   MUTAGEN         19
FT                   /note="I->A: Loss of binding to PPP1R12A."
FT                   /evidence="ECO:0000269|PubMed:10567269"
FT   MUTAGEN         26
FT                   /note="L->P: Loss of binding to PPP1R12A."
FT                   /evidence="ECO:0000269|PubMed:10567269"
FT   MUTAGEN         33
FT                   /note="I->A: Loss of binding to PPP1R12A."
FT                   /evidence="ECO:0000269|PubMed:10567269"
FT   MUTAGEN         40
FT                   /note="L->A: Loss of binding to PPP1R12A."
FT                   /evidence="ECO:0000269|PubMed:10567269"
FT   MUTAGEN         281
FT                   /note="L->A: Reduces cGMP binding affinity."
FT                   /evidence="ECO:0000269|PubMed:24239458"
FT   MUTAGEN         282
FT                   /note="R->A: Reduces cGMP binding affinity."
FT                   /evidence="ECO:0000269|PubMed:24239458"
FT   MUTAGEN         302
FT                   /note="T->A: Reduces cGMP binding affinity."
FT                   /evidence="ECO:0000269|PubMed:24239458"
FT   MUTAGEN         336
FT                   /note="Y->A: Reduces cGMP binding affinity."
FT                   /evidence="ECO:0000269|PubMed:24239458"
FT   HELIX           3..44
FT                   /evidence="ECO:0007829|PDB:4R4M"
FT   HELIX           88..100
FT                   /evidence="ECO:0007829|PDB:3OCP"
FT   TURN            102..106
FT                   /evidence="ECO:0007829|PDB:3OCP"
FT   HELIX           109..118
FT                   /evidence="ECO:0007829|PDB:3OCP"
FT   STRAND          120..124
FT                   /evidence="ECO:0007829|PDB:3OCP"
FT   STRAND          129..131
FT                   /evidence="ECO:0007829|PDB:3OCP"
FT   STRAND          139..145
FT                   /evidence="ECO:0007829|PDB:3OCP"
FT   STRAND          148..152
FT                   /evidence="ECO:0007829|PDB:3OCP"
FT   STRAND          155..160
FT                   /evidence="ECO:0007829|PDB:3OCP"
FT   STRAND          165..167
FT                   /evidence="ECO:0007829|PDB:3OCP"
FT   HELIX           169..173
FT                   /evidence="ECO:0007829|PDB:3OCP"
FT   STRAND          174..176
FT                   /evidence="ECO:0007829|PDB:3OD0"
FT   STRAND          178..185
FT                   /evidence="ECO:0007829|PDB:3OCP"
FT   STRAND          187..193
FT                   /evidence="ECO:0007829|PDB:3OCP"
FT   HELIX           194..201
FT                   /evidence="ECO:0007829|PDB:3OCP"
FT   HELIX           209..217
FT                   /evidence="ECO:0007829|PDB:5L0N"
FT   HELIX           220..222
FT                   /evidence="ECO:0007829|PDB:5L0N"
FT   HELIX           227..236
FT                   /evidence="ECO:0007829|PDB:5L0N"
FT   STRAND          238..242
FT                   /evidence="ECO:0007829|PDB:5L0N"
FT   STRAND          247..249
FT                   /evidence="ECO:0007829|PDB:5L0N"
FT   STRAND          257..264
FT                   /evidence="ECO:0007829|PDB:5L0N"
FT   STRAND          266..270
FT                   /evidence="ECO:0007829|PDB:5L0N"
FT   STRAND          274..276
FT                   /evidence="ECO:0007829|PDB:4KU8"
FT   STRAND          279..284
FT                   /evidence="ECO:0007829|PDB:5L0N"
FT   HELIX           292..296
FT                   /evidence="ECO:0007829|PDB:5L0N"
FT   STRAND          297..300
FT                   /evidence="ECO:0007829|PDB:4Z07"
FT   STRAND          303..317
FT                   /evidence="ECO:0007829|PDB:5L0N"
FT   HELIX           318..325
FT                   /evidence="ECO:0007829|PDB:5L0N"
FT   TURN            326..329
FT                   /evidence="ECO:0007829|PDB:5L0N"
FT   HELIX           339..353
FT                   /evidence="ECO:0007829|PDB:6BG2"
FT   HELIX           357..359
FT                   /evidence="ECO:0007829|PDB:6BG2"
FT   STRAND          360..368
FT                   /evidence="ECO:0007829|PDB:6BG2"
FT   STRAND          373..379
FT                   /evidence="ECO:0007829|PDB:6BG2"
FT   STRAND          386..393
FT                   /evidence="ECO:0007829|PDB:6BG2"
FT   HELIX           394..399
FT                   /evidence="ECO:0007829|PDB:6BG2"
FT   HELIX           403..415
FT                   /evidence="ECO:0007829|PDB:6BG2"
FT   STRAND          424..429
FT                   /evidence="ECO:0007829|PDB:6BG2"
FT   STRAND          431..439
FT                   /evidence="ECO:0007829|PDB:6BG2"
FT   HELIX           446..453
FT                   /evidence="ECO:0007829|PDB:6BG2"
FT   HELIX           458..477
FT                   /evidence="ECO:0007829|PDB:6BG2"
FT   HELIX           487..489
FT                   /evidence="ECO:0007829|PDB:6BG2"
FT   STRAND          490..492
FT                   /evidence="ECO:0007829|PDB:6BG2"
FT   STRAND          498..500
FT                   /evidence="ECO:0007829|PDB:6BG2"
FT   HELIX           522..524
FT                   /evidence="ECO:0007829|PDB:6BG2"
FT   HELIX           527..530
FT                   /evidence="ECO:0007829|PDB:6BG2"
FT   HELIX           538..553
FT                   /evidence="ECO:0007829|PDB:6BG2"
FT   HELIX           563..572
FT                   /evidence="ECO:0007829|PDB:6BG2"
FT   HELIX           574..576
FT                   /evidence="ECO:0007829|PDB:6BG2"
FT   HELIX           585..594
FT                   /evidence="ECO:0007829|PDB:6BG2"
FT   HELIX           599..601
FT                   /evidence="ECO:0007829|PDB:6BG2"
FT   TURN            607..609
FT                   /evidence="ECO:0007829|PDB:6BG2"
FT   HELIX           610..614
FT                   /evidence="ECO:0007829|PDB:6BG2"
FT   HELIX           617..619
FT                   /evidence="ECO:0007829|PDB:6BG2"
FT   HELIX           624..628
FT                   /evidence="ECO:0007829|PDB:6BG2"
FT   TURN            667..670
FT                   /evidence="ECO:0007829|PDB:6BG2"
SQ   SEQUENCE   671 AA;  76364 MW;  51389502A5E5FBD2 CRC64;
     MSELEEDFAK ILMLKEERIK ELEKRLSEKE EEIQELKRKL HKCQSVLPVP STHIGPRTTR
     AQGISAEPQT YRSFHDLRQA FRKFTKSERS KDLIKEAILD NDFMKNLELS QIQEIVDCMY
     PVEYGKDSCI IKEGDVGSLV YVMEDGKVEV TKEGVKLCTM GPGKVFGELA ILYNCTRTAT
     VKTLVNVKLW AIDRQCFQTI MMRTGLIKHT EYMEFLKSVP TFQSLPEEIL SKLADVLEET
     HYENGEYIIR QGARGDTFFI ISKGTVNVTR EDSPSEDPVF LRTLGKGDWF GEKALQGEDV
     RTANVIAAEA VTCLVIDRDS FKHLIGGLDD VSNKAYEDAE AKAKYEAEAA FFANLKLSDF
     NIIDTLGVGG FGRVELVQLK SEESKTFAMK ILKKRHIVDT RQQEHIRSEK QIMQGAHSDF
     IVRLYRTFKD SKYLYMLMEA CLGGELWTIL RDRGSFEDST TRFYTACVVE AFAYLHSKGI
     IYRDLKPENL ILDHRGYAKL VDFGFAKKIG FGKKTWTFCG TPEYVAPEII LNKGHDISAD
     YWSLGILMYE LLTGSPPFSG PDPMKTYNII LRGIDMIEFP KKIAKNAANL IKKLCRDNPS
     ERLGNLKNGV KDIQKHKWFE GFNWEGLRKG TLTPPIIPSV ASPTDTSNFD SFPEDNDEPP
     PDDNSGWDID F
//
